There are a few. For example Beth Israel has some
Post# of 72440
"In a statement, Cellceutix chief executive Leo Ehrlich said: “Beth Israel Deaconess Medical Center will be researching Kevetrin for indications in addition to those which we will be studying in our company-sponsored clinical trials. If they collect promising data in their research of Kevetrin in melanoma and renal cell carcinoma, additional grant and government funding may become available to further study these separate indications, saving us substantial time and money towards the end goal of commercialization.”
https://www.bostonglobe.com/business/2012/03/...story.html
There's just multiple parties invested in this project and its not wise to steal anyone's thunder.
*** I would love a positive update from Beth Israel on Kevetrin against melanoma or Renal Cell carcinoma. Especially since researchers have had such great results in vitro against renal cell CA.